- Home
- FRGT vs CNSP Comparison
FRGT vs CNSP Comparison
Compare FRGT & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGT
- CNSP
- Stock Information
- Founded
- FRGT 2015
- CNSP 2017
- Country
- FRGT Mexico
- CNSP United States
- Employees
- FRGT N/A
- CNSP N/A
- Industry
- FRGT Professional Services
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- FRGT Consumer Discretionary
- CNSP Health Care
- Exchange
- FRGT Nasdaq
- CNSP Nasdaq
- Market Cap
- FRGT 3.5M
- CNSP 4.0M
- IPO Year
- FRGT N/A
- CNSP 2019
- Fundamental
- Price
- FRGT $1.49
- CNSP $9.20
- Analyst Decision
- FRGT
- CNSP Strong Buy
- Analyst Count
- FRGT 0
- CNSP 1
- Target Price
- FRGT N/A
- CNSP $20.00
- AVG Volume (30 Days)
- FRGT 1.8M
- CNSP 76.5K
- Earning Date
- FRGT 08-18-2025
- CNSP 11-14-2025
- Dividend Yield
- FRGT N/A
- CNSP N/A
- EPS Growth
- FRGT N/A
- CNSP N/A
- EPS
- FRGT N/A
- CNSP N/A
- Revenue
- FRGT $12,693,870.00
- CNSP N/A
- Revenue This Year
- FRGT $371.03
- CNSP N/A
- Revenue Next Year
- FRGT N/A
- CNSP N/A
- P/E Ratio
- FRGT N/A
- CNSP N/A
- Revenue Growth
- FRGT N/A
- CNSP N/A
- 52 Week Low
- FRGT $1.15
- CNSP $4.93
- 52 Week High
- FRGT $16.70
- CNSP $221.94
- Technical
- Relative Strength Index (RSI)
- FRGT 55.85
- CNSP 69.22
- Support Level
- FRGT $1.17
- CNSP $5.88
- Resistance Level
- FRGT $1.50
- CNSP $6.37
- Average True Range (ATR)
- FRGT 0.16
- CNSP 0.55
- MACD
- FRGT 0.05
- CNSP 0.37
- Stochastic Oscillator
- FRGT 36.67
- CNSP 98.82
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.